Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022

SELL
$271.6 - $314.21 $230,860 - $267,078
-850 Closed
0 $0
Q2 2021

Jul 30, 2021

SELL
$251.87 - $278.14 $31,483 - $34,767
-125 Reduced 12.82%
850 $235,000
Q1 2021

Apr 26, 2021

BUY
$204.88 - $255.03 $199,758 - $248,654
975 New
975 $248,000
Q4 2020

Feb 10, 2021

SELL
$186.91 - $214.42 $313,074 - $359,153
-1,675 Closed
0 $0
Q3 2019

Nov 05, 2019

SELL
$159.77 - $178.1 $35,948 - $40,072
-225 Reduced 11.84%
1,675 $282,000
Q1 2019

Apr 19, 2019

SELL
$123.7 - $156.3 $12,370 - $15,630
-100 Reduced 5.0%
1,900 $291,000
Q2 2018

Jul 30, 2018

SELL
$160.33 - $189.41 $18,437 - $21,782
-115 Reduced 5.44%
2,000 $359,000
Q1 2018

Apr 27, 2018

SELL
$161.53 - $178.11 $11,307 - $12,467
-70 Reduced 3.2%
2,115 $342,000
Q4 2017

Feb 05, 2018

SELL
$147.99 - $163.95 $4,439 - $4,918
-30 Reduced 1.35%
2,185 $349,000
Q3 2017

Nov 01, 2017

BUY
$149.47 - $160.56 $331,076 - $355,640
2,215
2,215 $334,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Nixon Peabody Trust CO Portfolio

Follow Nixon Peabody Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nixon Peabody Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Nixon Peabody Trust CO with notifications on news.